FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs

The FDA has issued an alert to healthcare professionals warning about the risks of patients being exposed to xylazine, a veterinary sedative, in illicit drugs. The alert states that xylazine has been found in counterfeit versions of opioid drugs and other illicit substances, and can lead to serious side effects such as respiratory depression, coma, …

FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs Read More »